Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR2C | P28335 | 2/20 | 0.35 |
| ▸ | HTR2B | P41595 | 2/20 | 0.35 |
| ▸ | HTR2A | P28223 | 1/20 | 0.35 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.35 |
| ▸ | AADAT | Q8N5Z0 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.31 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.31 |
| ▸ | HTR6 | P50406 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16709143 | 0.86 | ALOX12 (0.40) | HTR2CHTR2BHTR2AALOX12AADAT | |
| SCHEMBL13875979 | 0.80 | HTR2A (0.33) | HTR2CHTR2BHTR2AAADATSLC6A2 | |
| SCHEMBL13875974 | 0.72 | ALDH1A1 (0.39) | HTR2CHTR2BHTR2AALOX12AADAT | |
| SCHEMBL13875987 | 0.68 | ALDH1A1 (0.38) | HTR2CHTR2BHTR2AALOX12AADAT | |
| SCHEMBL13875992 | 0.68 | ALDH1A1 (0.38) | HTR2CHTR2BHTR2AAADATSLC6A2 | |
| SCHEMBL13969349 | 0.67 | NISCH (0.34) | — | |
| SCHEMBL17952209 | 0.67 | CYP1A2 (0.33) | — | |
| SCHEMBL13875985 | 0.66 | HPGD (0.36) | HTR2CHTR2BHTR2AAADATGAA | |
| SCHEMBL12083455 | 0.66 | ALDH1A1 (0.36) | — | |
| SCHEMBL9891022 | 0.66 | ALDH1A1 (0.36) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11692131-B2 | Heteroleptic transition metal-carbene complexes and their use in organic light-emitting diodes | UDC IRELAND LIMITED (IE) | 2023-07-04 | — | — | US | disclosed |
| US-8877937-B2 | Process for preparing transition metal-carbene complexes | BASF SE (DE) | 2014-11-04 | — | — | US | disclosed |
| US-20130178621-A1 | PROCESS FOR PREPARING TRANSITION METAL-CARBENE COMPLEXES | BASF SE (DE) | 2013-07-11 | — | — | US | disclosed |
| US-8410280-B2 | Process for preparing transition metal-carbene complexes | BASF SE (DE) | 2013-04-02 | — | — | US | disclosed |
| US-8383828-B2 | Transition metal complexes comprising one noncarbene ligand and one or two carbene ligands and their use in OLEDs | BASF AKTIENGESELLSCHAFT (DE) | 2013-02-26 | — | — | US | disclosed |
| US-20090096367-A1 | HETEROLEPTIC TRANSITION METAL-CARBENE COMPLEXES AND THEIR USE IN ORGANIC LIGHT-EMITTING DIODES (OLEDS) | BASF SE (DE) | 2009-04-16 | — | — | US | disclosed |
| US-20090054657-A1 | Transition Metal Complexes Comprising One Noncarbene Ligand and One or Two Carbene Ligands and their Use in Oleds | BASF SE (DE) | 2009-02-26 | — | — | US | disclosed |
| US-20090018330-A1 | PROCESS FOR PREPARING TRANSITION METAL-CARBENE COMPLEXES | BASF SE (DE) | 2009-01-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090018330-A1 | PROCESS FOR PREPARING TRANSITION METAL-CARBENE COMPLEXES | AP1M1, C1S, GPS1 | HTR2C 4613/4885HTR2B 3442/4885HTR2A 4327/4885 |
| US-20090096367-A1 | HETEROLEPTIC TRANSITION METAL-CARBENE COMPLEXES AND THEIR USE IN ORGANIC LIGHT-EMITTING DIODES (OLEDS) | OCIAD2, OCIAD1, ICOSLG | HTR2C 1279/4885HTR2B 1293/4885HTR2A 1921/4885 |
| US-20130178621-A1 | PROCESS FOR PREPARING TRANSITION METAL-CARBENE COMPLEXES | AP1M1, C1S, GPS1 | HTR2C 4613/4885HTR2B 3442/4885HTR2A 4327/4885 |
| US-20090054657-A1 | Transition Metal Complexes Comprising One Noncarbene Ligand and One or Two Carbene Ligands and their Use in Oleds | OCIAD1, OCIAD2, ICOSLG | HTR2C 1278/4885HTR2B 1546/4885HTR2A 1944/4885 |
| US-11692131-B2 | Heteroleptic transition metal-carbene complexes and their use in organic light-emitting diodes | CLTB, CLTC, CYBA | HTR2C 1562/4885HTR2B 1468/4885HTR2A 1956/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.